TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Edema Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of attacks of headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sit to Stand (STS) test of the NeuroCom® Balance Master®
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in International Knee Documentation Committee (IKDC) Subjective Knee Form Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Lysholm Scale Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Repair Failure
Endpoint domain: Adverse events/effects
Primary endpoint: Numerical Rating Pain Scale (NRPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients cured
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Adverse effects on liver function tests
Endpoint domain: Adverse events/effects
Primary endpoint: Length of Overall Survival
Endpoint domain: Mortality/survival
Primary endpoint: Change in depression, stress, and anxiety symptomatology scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fecal Microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SCFA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Inflammatory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: global tolerance of the medical device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCinf (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of LTG-305
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacodynamics of LTG-305
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to central nervous system (CNS) progression (CNSprog)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of skeletal muscle index (SMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Acceptability of THRIVE intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of THRIVE intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Client Satisfaction Survey
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient recruitment and retention rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Tumor size and number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Determination of the MTD and/or RP2D based on DLTs
Endpoint domain: Adverse events/effects
Primary endpoint: The number of treatment discontinuation or dose reduction
Endpoint domain: Adverse events/effects
Primary endpoint: AEs (Adverse event)
Endpoint domain: Adverse events/effects
Primary endpoint: Correction rate of axial rotation of the apex vertebrae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Emotional Regulation Task performance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of postoperative sepsis
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of mispositioned stents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: semen index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: ciprofloxacin prescription frequency
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quality of life in toddlers
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Montreal Cognitive Assessment (MOCA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of Autonomic Dysreflexia episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average air conduction pure-tone threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Word recognition score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average air bone gap
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance hyoid-carotid artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Carotid artery position in regard to ipsilateral greater horn of the hyoid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Hyoid bone morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative Atrial Fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficacy of CIM method for H. pylori detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Post-operative mobility
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Body temperature data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Value of Montreal Cognitive Assessment (MoCA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of drug-related complications after 6 months
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in maximum oxygen uptake at peak exercise (VO2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of Malnutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prediction of Outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour average intestinal sound rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of referred children attending hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Frequency of immune cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PVTT Response Rate (RR) / Non-Response Rate (NR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of pertussis cases
Endpoint domain: Mortality/survival
Primary endpoint: Recurrence of Pneumothorax
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Beta diversity of the vaginal microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Psychotic transition in UHR
Endpoint domain: Mortality/survival
Primary endpoint: Successful LMA placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Left ventricular end-systolic volume (LVESV) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Resting Cardiovascular Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Safety and tolerability of THEO-260
Endpoint domain: Adverse events/effects
Primary endpoint: Establish recommended Phase 2 dose (RP2D) for THEO-260
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Evaluate preliminary efficacy of THEO-260
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pre Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Delta power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Parenting Self-efficacy and Competence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in observed parent-child interaction and emotional connection
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Child Behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of clinically significant abnormalities in safety laboratory values
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in vital sign measurement: Systolic blood pressure (mmHg) and Diastolic blood pressure (mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Startle reactivity to stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in serum metal ion levels (Cobalt and Chrome)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in psychosocial function
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in sensorimotor function - vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Provider participant recruitment rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in provider participant assessment completion rates at post-training
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in the adoption of practices learned in the training intervention at 12-month followup
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: mBI long term
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mBI short term
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: residual plaque and calculus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in olfaction threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in minutes of daily sedentary time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores of the Morisky scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean antral cross-sectional area of stomach
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: PHQ-9 (Patient Health Questionnaire - 9 items)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: GAD-7 (Generalised Anxiety Disorder Assessment - 7 items)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CGI-S (Clinical Global Impressions - Severity Scale)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Muscle thickness of the transverse abdominis muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Physical Function (6-minute walk test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hip adductor spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Assessment of Joint Range of Motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mortality rate through 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Unplanned procedure-related readmission rate through 30 days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Acceptability of music intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patients' preference of music intervention
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: posterior capsule diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Yale-Brown Obsessive Compulsive Scale (YBOCS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Montgomery-Asberg Depression Rating Scale (MADRS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with HIV-1 RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in CD4 T cell count from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Attendance at behavioral coaching sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Engagement of social network members in the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completion of final study assessment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Functional Itch Disorder Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline strength in kilograms at 10 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline cardiorespiratory fitness in number of steps performed at 10 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline postural control in arbitrary units at 10 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unified Parkinson's Disease Rating Scale Ib & II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognition Change
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Underwater endurance change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial PCO2 change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilatory chemosensitivity change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of MMRd caused by MLH1 promoter methylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rates of initiation of breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Eating behavior change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient satisfaction with the EWMS intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mortality or severe neurological deficits
Endpoint domain: Mortality/survival
Primary endpoint: Range of motion of hands and arms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients requiring re-insertion of a transurethral urinary catheter
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Soleus V-wave amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maximum isometric muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: change in total body fat percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in abdominal subcutaneous fat percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in abdominal visceral fat percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in Irritable bowel syndrome Severity Scoring system (IBS-SSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: change in Irritable bowel syndrome-quality of life (IBS-QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Risk of pressure sores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time to Return to Full Activity or Sports
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Recurrent Knee Instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PROMIS Physical Function (PF) CAT
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pain using Numeric Pain Rating Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in ankle position sense degree
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in vertical jump distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in myotonometric characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) 0-t
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum (or peak) serum concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to achieve maximum drug concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life Scale for Children (QoL-C)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of subjects with serious and non-serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Median ACT score at 6 and 12 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Median of total and severe exacerbations at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median healthcare resources use at 12 months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Parent reported respiratory symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Patient Health Questionnaire-8 (PHQ-8)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Platelet decline rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Maximum Phonation Time (MPT) in seconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Dyspnea measured by Dyspnea-12 Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of CBT4CBT use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of CBT4CBT
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 1-year flare rate of lupus nephritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pittsburg Sleep Quality Index score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Scoliosis Research Society-22 questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in Trigger Points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in glucose excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Completed Covid tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: AgRP change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Total amount of dummy-inhaled virus copies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of RSV LRTI hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Number of Subjects who meet LDL at goal (<55)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in number of ramp stages for hemodynamic optimization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of sinus rhythm restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adherence to allocation groups
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Completion of follow-up of included patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Amount of blood transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Measure #1
Endpoint domain: null
Endpoint subdomain: null
Primary endpoint: Measure #2
Endpoint domain: null
Endpoint subdomain: null
Primary endpoint: Number of Participants With Changes in Suicidal Ideation or Suicidal Behavior Assessed Using the Columbia Suicide-Severity Rating Scale (C-SSRS)
Endpoint domain: Adverse events/effects
Primary endpoint: Device/Surgery-Related Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Device/Surgery Adverse Event Rate
Endpoint domain: Adverse events/effects
Primary endpoint: tcPCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mitoPO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short-Form 36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Injustice Experience Questionnaire (IEQ) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient Health Questionnaire-8 (PHQ-8) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bladder morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bladder behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes